Canal Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-107,340	Closed	-$5.82M	–	148
2024 Q1	$5.82M	Buy	107,340 +51,308	+92%	+$2.61M	0.98%	33
2023 Q4	$2.87M	Sell	56,032 -23,349	-29%	-$1.23M	0.53%	50
2023 Q3	$4.61M	Buy	79,381 +2,225	+3%	+$136K	0.94%	34
2023 Q2	$4.93M	Buy	77,156 +1,956	+3%	+$131K	1%	29
2023 Q1	$5.21M	Buy	75,200 +2,129	+3%	+$150K	1.15%	25
2022 Q4	$5.26M	Buy	73,071 +2,913	+4%	+$220K	1.28%	22
2022 Q3	$4.99M	Buy	70,158 +3,674	+6%	+$267K	1.46%	10
2022 Q2	$5.12M	Buy	66,484 +1,761	+3%	+$134K	1.53%	10
2022 Q1	$4.73M	Buy	64,723 +3,341	+5%	+$224K	1.28%	19
2021 Q4	$3.83M	Buy	61,382 +6,085	+11%	+$357K	0.92%	32
2021 Q3	$3.27M	Sell	55,297 -146	-0.3%	-$9.62K	0.93%	33
2021 Q2	$3.71M	Buy	55,443 +1,555	+3%	+$101K	1.07%	28
2021 Q1	$3.4M	Buy	53,888 +4,482	+9%	+$279K	1.16%	27
2020 Q4	$3.06M	Buy	49,406 +2,385	+5%	+$147K	1.16%	29
2020 Q3	$2.83M	Sell	47,021 -215	-0.5%	-$12.9K	1.24%	25
2020 Q2	$2.78M	Buy	47,236 +685	+1%	+$41K	1.36%	22
2020 Q1	$2.6M	Buy	46,551 +907	+2%	+$55.4K	1.46%	25
2019 Q4	$2.93M	Sell	45,644 -116	-0.3%	-$6.64K	1.48%	21
2019 Q3	$2.32M	Buy	45,760 +2,911	+7%	+$137K	1.39%	29
2019 Q2	$1.94M	Buy	+42,849	New	+$2M	1.18%	32